Literature DB >> 16287064

Seventy-five years is an appropriate upper age limit for population-based mammography screening.

Jacques Fracheboud1, Johanna Helëne Groenewoud, Rob Boer, Gerrit Draisma, Arry E de Bruijn, André L M Verbeek, Harry J de Koning.   

Abstract

In this study, we assessed the results of the Dutch breast cancer screening programme for women aged 70-75, and discussed the current upper age limit of the women invited. We compared the main outcome parameters of the screening programme 1998-2000 for women aged 70-75, with those in women aged 50-69. Breast cancer detection rates were also compared with prediction from 2 variants of a simulation model of breast cancer screening, assuming the mean sojourn time, i.e., the duration of the preclinical detectable phase, to increase or not with age above the age of 65. The underlying idea is that an increase of the sojourn time with age will lead to a less favourable balance between screening benefits and harms from a certain age on. Of the 315,103 women (aged 70-75) invited, 65.6% participated. The attendance increased from 1998 to 2000. For women aged 74 and 75 years, this increase was almost 10%. As a result of the 187,207 screening examinations performed within this age group, 18.3 per 1,000 women were referred and 10.3 per 1,000 breast cancer were diagnosed. Detection rates in both initial and subsequent screens increased steadily with age and got close to those model-simulated rates, which assume a continuously increasing sojourn time with age. A major finding of this study is that the screening participation among elderly women is high. The outcomes of our study suggest a steadily increasing sojourn time of breast tumours beyond the age of 69, leading to a strong increase in detection of cancers, and therefore, disfavouring the balance with the benefits of screening. At present, 75 years of age can be regarded as an appropriate upper age limit for the Dutch programme. Copyright (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16287064     DOI: 10.1002/ijc.21560

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  [Negative influence of undertreatment in elderly patients with breast cancer].

Authors:  F A Giordano; F Wenz
Journal:  Strahlenther Onkol       Date:  2012-06       Impact factor: 3.621

Review 2.  The benefits and harms of breast cancer screening: an independent review.

Authors:  M G Marmot; D G Altman; D A Cameron; J A Dewar; S G Thompson; M Wilcox
Journal:  Br J Cancer       Date:  2013-06-06       Impact factor: 7.640

3.  Modeling the impact of population screening on breast cancer mortality in the United States.

Authors:  Jeanne S Mandelblatt; Kathleen A Cronin; Donald A Berry; Yaojen Chang; Harry J de Koning; Sandra J Lee; Sylvia K Plevritis; Clyde B Schechter; Natasha K Stout; Nicolien T van Ravesteyn; Marvin Zelen; Eric J Feuer
Journal:  Breast       Date:  2011-10       Impact factor: 4.380

Review 4.  Calibration methods used in cancer simulation models and suggested reporting guidelines.

Authors:  Natasha K Stout; Amy B Knudsen; Chung Yin Kong; Pamela M McMahon; G Scott Gazelle
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

5.  Lung cancer detectability by test, histology, stage, and gender: estimates from the NLST and the PLCO trials.

Authors:  Kevin Ten Haaf; Joost van Rosmalen; Harry J de Koning
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-10-13       Impact factor: 4.254

6.  Optimal Breast Biopsy Decision-Making Based on Mammographic Features and Demographic Factors.

Authors:  Jagpreet Chhatwal; Oguzhan Alagoz; Elizabeth S Burnside
Journal:  Oper Res       Date:  2010-11-01       Impact factor: 3.310

7.  Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms.

Authors:  Jeanne S Mandelblatt; Kathleen A Cronin; Stephanie Bailey; Donald A Berry; Harry J de Koning; Gerrit Draisma; Hui Huang; Sandra J Lee; Mark Munsell; Sylvia K Plevritis; Peter Ravdin; Clyde B Schechter; Bronislava Sigal; Michael A Stoto; Natasha K Stout; Nicolien T van Ravesteyn; John Venier; Marvin Zelen; Eric J Feuer
Journal:  Ann Intern Med       Date:  2009-11-17       Impact factor: 25.391

8.  Determining use of preventive health care in Ontario: comparison of rates of 3 maneuvers in administrative and survey data.

Authors:  Li Wang; X Nie Jason; Ross E G Upshur
Journal:  Can Fam Physician       Date:  2009-02       Impact factor: 3.275

9.  Rising incidence of breast cancer among female cancer survivors: implications for surveillance.

Authors:  I Soerjomataram; W J Louwman; L E M Duijm; J W W Coebergh
Journal:  Br J Cancer       Date:  2008-12-09       Impact factor: 7.640

10.  By invitation only - the case for breast cancer screening reminders for women over 69 years.

Authors:  Carla Saunders; Monica Robotin; Sally Crossing
Journal:  Aust New Zealand Health Policy       Date:  2008-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.